GLP-1 drugs are fueling the rise of the 'big kids' market, one mega restaurant chain says
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
This article was originally published at: https://www.businessinsider.com/cava-glp-1-drugs-big-kids...